Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003271
Filing Date
2018-04-27
Accepted
2018-04-27 08:30:55
Documents
5
Period of Report
2018-06-15
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2235469zdef14a.htm DEF 14A 319978
2 G813071.JPG g813071.jpg GRAPHIC 14244
3 G677075.JPG g677075.jpg GRAPHIC 10007
4 G30872BGI001.GIF g30872bgi001.gif GRAPHIC 86113
5 G30872BGI002.GIF g30872bgi002.gif GRAPHIC 71334
  Complete submission text file 0001047469-18-003271.txt   571714
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37687 | Film No.: 18781122
SIC: 2836 Biological Products, (No Diagnostic Substances)